L-
Nahrungsergnzungsmittel bei Einnahme von GLP-1-Medikamenten (Ozempic, Wegovy, Mounjaro, Semaglutid oder Tirzepatid) GLP-1-Rezeptor-Agonisten wie Semaglutid (Ozempic, Wegovy) und Tirzepatid (Mounjaro ) sind wirksam bei der Gewichtskontrolle, da sie das krpereigene GLP-1-Hormon imitieren
Outperforms Other Medications: In some studies, Mounjaro has even outperformed other injectable medications like semaglutide ( Wegovy ), showcasing its potential for effective weight management
Patients at GLOW with documented deficiency often notice improved energy levels within 48 to 72 hours of their first injection
Non-GMO NOTE: If you have a medical condition, are pregnant, lactating, trying to conceive, under the age of 18, or taking medications, consult your healthcare professional before using this product.